Evidence map›Paper›PMID 39106239›Full record

ArticlePLoS neglected tropical diseases2024

Southern African Origin of HTLV-1 in Romania.

Olivier Cassar, Ambroise Marçais, Olivier Hermine, Emilie Deruelle, Giovanni Begliomini, Alexandru Bardas, Horia Bumbea, Andrei Colita, Daniel Coriu, Viola Maria Popov and 3 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Olivier CassarInstitut Pasteur, Université Paris Cité, CNRS UMR 3569, Unité d'Épidémiologie et Physiopathologie des Virus Oncogènes, Département de Virologie, Paris, France.ORCID 0000-0001-5331-6357
Ambroise MarçaisHôpital Necker-Enfants Malades, Service d'Hématologie, Paris, France.
Olivier HermineHôpital Necker-Enfants Malades, Service d'Hématologie, Paris, France.
Emilie DeruelleHôpital Necker-Enfants Malades, Service d'Hématologie, Paris, France.
Giovanni BegliominiInstitut Pasteur, Université Paris Cité, CNRS UMR 3569, Unité d'Épidémiologie et Physiopathologie des Virus Oncogènes, Département de Virologie, Paris, France.
Alexandru BardasFundeni Clinical Institute, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
Horia BumbeaEmergency University Hospital, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
Andrei ColitaColtea Hospital, University of Medicine and Pharmacy Carol Davila, Department of Hematology, Bucharest, Romania.
Daniel CoriuFundeni Clinical Institute, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
Viola Maria PopovColentina Clinical Hospital, Hematology 1 Department, Bucharest, Romania.
Alina TanaseFundeni Clinical Institute, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
Philippe Vicente AfonsoInstitut Pasteur, Université Paris Cité, CNRS UMR 3569, Unité d'Épidémiologie et Physiopathologie des Virus Oncogènes, Département de Virologie, Paris, France.
Antoine GessainInstitut Pasteur, Université Paris Cité, CNRS UMR 3569, Unité d'Épidémiologie et Physiopathologie des Virus Oncogènes, Département de Virologie, Paris, France.

Funding

Centre National de la Recherche Scientifique CNRS-UMR 3569French Government’s Investissement d’Avenir Program, Laboratoire d’Excellence “Integrative Biology of Emerging Infectious Diseases” ANR-10-LABX-62-IBEID
6 · The paper itself

Abstract

In Europe, most HTLV-1-infected individuals originate from highly endemic regions such as West Indies, sub-Saharan Africa, and South America. The only genuine endemic region for HTLV-1 in Europe is Romania where ATL series have been reported among Romanian patients. Our objective is to better understand the origin of this endemic focus based on a study of the genetic diversity of HTLV-1 in Romanians. DNA was obtained from PBMCs/buffy coats of 11 unrelated HTLV-1-infected individuals of Romanian origin. They include 9 ATL cases and 2 asymptomatic carriers. LTR sequences were obtained for all specimens. Complete genomic HTLV-1 sequences were obtained using four PCR series on 10 specimens. Phylogenetic trees were generated from multiple alignments using HTLV-1 prototypic sequences and the new generated sequences. Most of the complete LTR sequences (756-bp) showed low nucleotide diversity, ranging from 0% to 0.8% difference, and were closely related (less than 0.8% divergence) to the only previously characterized Romanian strain, RKI2. One strain, ROU7, diverged slightly (1.5% on average) from the others. Phylogenetic analyses both on partial LTR and the complete genome demonstrate that the 11 sequences belong to the HTLV-1a cosmopolitan genotype and 10 of them belong to the previously denominated a-TC Mozambique-Southern Africa A subgroup. In this study, we demonstrated that the HTLV-1 present in Romania most probably originated in Southern Africa. As most Romanian HTLV-1 strains are very closely related, we can assume that HTLV-1 has been introduced into the Romanian population recently. Further studies are ongoing to decipher the routes of arrival and dissemination of these HTLV-1 strains, and to date the emergence of this endemic focus in Central Europe.

Indexed as

Genetic VariationHTLV-I InfectionsHuman T-lymphotropic virus 1PhylogenyTerminal Repeat SequencesAdultAfrica, SouthernAgedDNA, ViralFemaleHumansMaleMiddle AgedRomaniaSequence Analysis, DNADNA, Viral

Identifiers

PMID39106239
PMCPMC11302904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.